MedTrace Logo

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

NCT07364877 · Status: ENROLLING_BY_INVITATION · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-01-23

No results posted yet for this study

Summary

Safety and pharmacokinetic characteristics evaluation of DW4421 and DW4421S

Conditions

  • Healthy Adult Volunteer

Interventions

DRUG

DW4421

DW4421 or DW4421S

DRUG

DW4421S

DW4421 or DW4421S

Sponsors & Collaborators

  • Daewon Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-28
Primary Completion
2026-03-19
Completion
2026-05-18

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07364877 on ClinicalTrials.gov